SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-10-037851
Filing Date
2010-07-13
Accepted
2010-07-13 16:55:43
Documents
8
Group Members
APTAFIN S.P.A.CLAUDIO CAVAZZADEFIANTE FARMACEUTICA S.A.PAOLO CAVAZZASINAF S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a10-13888_1sc13da.htm SC 13D/A 239804
2 EX-14 a10-13888_1ex14.htm EX-14 29111
3 EX-15 a10-13888_1ex15.htm EX-15 10663
4 EX-16 a10-13888_1ex16.htm EX-16 5246
5 EX-17 a10-13888_1ex17.htm EX-17 5248
6 EX-18 a10-13888_1ex18.htm EX-18 7773
7 EX-19 a10-13888_1ex19.htm EX-19 10136
8 EX-20 a10-13888_1ex20.htm EX-20 36395
  Complete submission text file 0001104659-10-037851.txt   346331
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Subject) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43408 | Film No.: 10950673
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 00144 ROME ITALY
Business Address
SIGMA TAU FINANZIARIA SPA (Filed by) CIK: 0001092601 (see all company filings)

Fiscal Year End: 1231
Type: SC 13D/A